Associated Papers
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
Liu H et al.
Bmc Cancer, 2024
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.
Chia YC et al.
Diagnostics (basel, Switzerland), 2023
Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers.
Bignucolo A et al.
Expert Review of Clinical Pharmacology, 2022
Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.
Liu W et al.
Frontiers in Oncology, 2019
Association of OGG1 and MTHFR polymorphisms with age-related cataract: A systematic review and meta-analysis.
Wu X et al.
Plos One, 2017
Association between the X-ray repair cross-complementing group 1 Arg194Trp polymorphism and thyroid carcinoma susceptibility: A meta-analysis.
Zhao JZ et al.
Genetics and Molecular Research : Gmr, 2016
Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis.
Wang S et al.
Bmc Medical Genetics, 2015
Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
Jiang H et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2013
Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study.
Nissar S et al.
Oncology Letters, 2013
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
Cecchin E et al.
The Pharmacogenomics Journal, 2011
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.
Seripa D et al.
Ageing Research Reviews, 2009
Pharmacogenetics of cancer chemotherapy.
Abraham J et al.
Biochimica Et Biophysica Acta, 2006
Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?
Suh KW et al.
Annals of Surgical Oncology, 2006
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
[Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to cancer of the gastric cardia in Chinese population].
Miao X et al.
Zhonghua Yi Xue Za Zhi, 2002
Interaction Between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Environment with Susceptibility to Ischemic Stroke in Chinese Population.
Zheng XZ et al.
Annals of Indian Academy of Neurology, 0